Dagestan Cardiology Center has pioneered a novel surgical approach in the North Caucasian region for treating aortic valve disease. This procedure involves replacing the diseased aortic valve with a bioprosthesis constructed from the patient's own pericardium, a membrane surrounding the heart.

This innovative technique offers several advantages: it eliminates the need for lifelong anticoagulant medication, reduces the risk of implant rejection due to its biological compatibility, and exhibits high reliability rates. Furthermore, it can be integrated with other complex cardiac interventions as needed.

Recently, a 67-year-old female patient suffering from severe aortic stenosis underwent successful Ozaki surgery in conjunction with coronary artery bypass grafting at the center. Following a comprehensive rehabilitation program, the patient has resumed an active lifestyle. This groundbreaking surgical technique has garnered recognition within the field of specialized cardiac surgery, as evidenced by its publication in respected scientific journals.